GSK plc (GSK)

NYQ – Real vaqt narxi. Valyuta: USD

50.30

-0.60 (-1.18%)

Bozor ochiq: Aug 12, 2026, 12:59 PM EDT

51.62

+0.72 (1.41%)

Oldingi bozordan keyin: Aug 11, 2026, 7:53 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

11.08.2026

Trump wants to split the MMR vaccine. Experts say that's unlikely — and comes with consequences

President Donald Trump's latest executive order calls for splitting the measles, mumps and rubella, or MMR, vaccine into three separate shots. But doctors and other experts say that effort has no scientific basis and is unlikely to get off the ground.

03.08.2026

GSK India first-quarter profit rises on steady vaccine demand

Vaccine maker GlaxoSmithKline Pharmaceuticals reported a 15.7% rise in first-quarter profit on Monday, aided by stable demand across its vaccine and drug portfolio, including ‌respiratory and specialty medicines.

Videolar

No Data

There is no data to display

GSK plc (GSK)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

GSK plc (GSK)

Trump wants to split the MMR vaccine. Experts say that's unlikely — and comes with consequences

GSK India first-quarter profit rises on steady vaccine demand

Videolar

No Data

Trump wants to split the MMR vaccine. Experts say that's unlikely — and comes with consequences

GSK India first-quarter profit rises on steady vaccine demand

Videolar

No Data

Search stocks

GSK plc (GSK)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

GSK plc (GSK)

Trump wants to split the MMR vaccine. Experts say that's unlikely — and comes with consequences

GSK India first-quarter profit rises on steady vaccine demand

Videolar

No Data

Trump wants to split the MMR vaccine. Experts say that's unlikely — and comes with consequences

GSK India first-quarter profit rises on steady vaccine demand

Videolar

No Data